Accession Number:

ADA581491

Title:

Genetic and Epigenetic Biomarkers for Recurrent Prostate Cancer After Radiotherapy

Descriptive Note:

Annual rept. 1 May 2012-30 Apr 2013

Corporate Author:

H LEE MOFFITT CANCER CENTER AND RESEARCH INST TAMPA FL

Personal Author(s):

• Park, Jong

Report Date:

2013-05-01

Pagination or Media Count:

7.0

Abstract:

t is not clear why some prostate cancers are aggressive and progress to metastasis. Accumulating evidence suggests that the angiogenesis pathway may play a critical role. The significance of angiogenesis in prostate cancer is demonstrated by its correlation with Gleason score, clinical stage, progression, metastasis and survival. However, relatively few studies have assessed the role of genes involved in angiogenesis in recurrence of prostate cancer after radiotherapy. On the basis of strong biological rationale, we propose to comprehensively study this pathway in a well-characterized cohort of prostate cancer cases. Our hypothesis is that genetic and epigenetic individual variation in angiogenesis genes is associated with recurrence of prostate cancer after radiotherapy. We will test this hypothesis with a systematic evaluation of the 82 key genes in the angiogenesis pathway with recurrence of prostate cancer. The ultimate goal of this study is to identify biomarkers that can be used at the time of diagnosis to predict risk of recurrence and improve clinical treatment decision making.

Descriptors:

• *GENETICS
• *PROSTATE CANCER
• *RADIOTHERAPY
• ANGIOGENESIS
• CLINICAL MEDICINE
• GENES
• METASTASIS
• PROSTATE GLAND
• RISK
• TEST AND EVALUATION
• TRACER STUDIES

Subject Categories:

• Genetic Engineering and Molecular Biology
• Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE